Lower riskDrug recall · FDA · Published August 5, 2019
RemedyRePack Lisinopril/HCTZ 20mg/12.5mg Tablets Recall: Foreign Tablets Found
RemedyRePack recalls 30-tablet blister packs of Lisinopril/HCTZ 20mg/12.5mg due to foreign tablets found in some bottles. Affected lots from 2019-09-30 expiry.
Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.
Take action
Contact the company
📍Recalling firmRemedyRepack Inc.625 Kolter Dr Ste 4 · Indiana, PA 15701-3571
“RemedyRePack Lisinopril/HCTZ 20mg/12.5mg Tablets Recall: Foreign Tablets Found.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38198-remedyrepack-lisinopril-hctz-20mg-12-5mg-tablets-recall-foreign-tablets. Based on FDA recall #D-1030-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1030-2020%22&limit=1).
The FDA announced on 2019-08-05 that RemedyRePack Inc. is recalling Lisinopril/HCTZ 20mg/12.5mg tablets due to the presence of foreign fenofibrate tablets, according to Agency recall number D-1030-2020.
How to tell if you have it
Brand: RemedyRePack
Product: Lisinopril/HCTZ 20mg/12.5mg Tablet
Quantity: 30 tablets per blister card
Manufacturer: Lupin Pharma Baltimore, MD 21202
NDCs: 68180-0519-02, 70518-0382-03
Lot #: J0322819-091418
Expiration: 09/30/2019
Distribution: PA
The hazard
The recall addresses a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle, according to the FDA. This is classified as a Class II recall.
Context
GovInfoNow's records show RemedyRePack Inc. has 35 other recalls on record since 2015-02-18. Recent recalls include Clindamycin Capsules due to CGMP Deviations reported on 2025-04-22 and 2025-03-24, as well as Carvedilol Tablets recalled on 2025-01-24 for N-Nitroso Impurity Risk. Other recent recalls of similar products include Bionpharma Divalproex Tablets Recall (2026-06-26), Annora Pharma Pitavastatin Tablets 2mg Recall (2026-02-03), and Golden State Baclofen Tablets Recall (2025-11-26).
How to tell if you have this one
Check for the NDC numbers 68180-0519-02 (original) or 70518-0382-03 (repackaged) on the blister pack. The lot number J0322819-091418 and expiration date 09/30/2019 are also specific to this recall.
Brand
RemedyRePack
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Product
Look for the NDC numbers 68180-0519-02 or 70518-0382-03 on the blister pack, and the lot number J0322819-091418 with expiration 09/30/2019.
Where it went and when
Where it was distributed
Distributed in Pennsylvania.
Listed by the agency
Not listed
FDA distribution: “PA” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Pennsylvania.
Recall timeline
FDA terminated this recall 3.8 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1030-2020 (August 5, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1030-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.